Literature DB >> 20442205

Menopause-associated symptoms and cognitive performance: results from the study of women's health across the nation.

Gail A Greendale1, Richard G Wight, Mei-Hua Huang, Nancy Avis, Ellen B Gold, Hadine Joffe, Teresa Seeman, Marike Vuge, Arun S Karlamangla.   

Abstract

A long-standing, but unproven hypothesis is that menopause symptoms cause cognitive difficulties during the menopause transition. This 6-year longitudinal cohort study of 1,903 midlife US women (2000-2006) asked whether symptoms negatively affect cognitive performance during the menopause transition and whether they are responsible for the negative effect of perimenopause on cognitive processing speed. Major exposures were depressive, anxiety, sleep disturbance, and vasomotor symptoms and menopause transition stages. Outcomes were longitudinal performance in 3 domains: processing speed (Symbol Digit Modalities Test (SDMT)), verbal memory (East Boston Memory Test), and working memory (Digit Span Backward). Adjustment for demographics showed that women with concurrent depressive symptoms scored 1 point lower on the SDMT (P < 0.05). On the East Boston Memory Test, the rate of learning among women with anxiety symptoms tested previously was 0.09 smaller per occasion (P = 0.03), 53% of the mean learning rate. The SDMT learning rate was 1.00 point smaller during late perimenopause than during premenopause (P = 0.04); further adjustment for symptoms did not attenuate this negative effect. Depressive and anxiety symptoms had a small, negative effect on processing speed. The authors found that depressive, anxiety, sleep disturbance, and vasomotor symptoms did not account for the transient decrement in SDMT learning observed during late perimenopause.

Entities:  

Mesh:

Year:  2010        PMID: 20442205      PMCID: PMC2915492          DOI: 10.1093/aje/kwq067

Source DB:  PubMed          Journal:  Am J Epidemiol        ISSN: 0002-9262            Impact factor:   4.897


  45 in total

Review 1.  Insomnia: prevalence, impact, pathogenesis, differential diagnosis, and evaluation.

Authors:  Philip M Becker
Journal:  Psychiatr Clin North Am       Date:  2006-12

Review 2.  Estrogen, menopause, and the aging brain: how basic neuroscience can inform hormone therapy in women.

Authors:  John H Morrison; Roberta D Brinton; Peter J Schmidt; Andrea C Gore
Journal:  J Neurosci       Date:  2006-10-11       Impact factor: 6.167

3.  The association between different cognitive domains and age in a multi-centre study of middle-aged and older European men.

Authors:  David M Lee; Abdelouahid Tajar; Aslan Ulubaev; Neil Pendleton; Terence W O'Neill; Daryl B O'Connor; Gyorgy Bartfai; Steven Boonen; Felipe F Casanueva; Joseph D Finn; Gianni Forti; Aleksander Giwercman; Thang S Han; Ilpo T Huhtaniemi; Krzysztof Kula; Michael E J Lean; Margus Punab; Alan J Silman; Dirk Vanderschueren; Frederick C W Wu
Journal:  Int J Geriatr Psychiatry       Date:  2009-11       Impact factor: 3.485

4.  Symptoms during the perimenopause: prevalence, severity, trajectory, and significance in women's lives.

Authors:  Nancy Fugate Woods; Ellen Sullivan Mitchell
Journal:  Am J Med       Date:  2005-12-19       Impact factor: 4.965

5.  Longitudinal analysis of the association between vasomotor symptoms and race/ethnicity across the menopausal transition: study of women's health across the nation.

Authors:  Ellen B Gold; Alicia Colvin; Nancy Avis; Joyce Bromberger; Gail A Greendale; Lynda Powell; Barbara Sternfeld; Karen Matthews
Journal:  Am J Public Health       Date:  2006-05-30       Impact factor: 9.308

6.  Hot flashes and estrogen therapy do not influence cognition in early menopausal women.

Authors:  Erin S LeBlanc; Michelle B Neiss; Phyllis E Carello; Mary H Samuels; Jeri S Janowsky
Journal:  Menopause       Date:  2007 Mar-Apr       Impact factor: 2.953

7.  A longitudinal study of cognition change during early menopausal transition in a rural community.

Authors:  Jong-Ling Fuh; Shuu-Jiun Wang; Shin-Jung Lee; Shiang-Ru Lu; Kai-Dih Juang
Journal:  Maturitas       Date:  2005-09-27       Impact factor: 4.342

8.  Neuropsychological functions in anxiety disorders in population-based samples: evidence of episodic memory dysfunction.

Authors:  Eija Airaksinen; Maria Larsson; Yvonne Forsell
Journal:  J Psychiatr Res       Date:  2005-03       Impact factor: 4.791

9.  Depressive symptoms as a predictor of cognitive decline: MacArthur Studies of Successful Aging.

Authors:  Joshua Chodosh; Deborah M Kado; Teresa E Seeman; Arun S Karlamangla
Journal:  Am J Geriatr Psychiatry       Date:  2007-05       Impact factor: 4.105

10.  Risk for new onset of depression during the menopausal transition: the Harvard study of moods and cycles.

Authors:  Lee S Cohen; Claudio N Soares; Allison F Vitonis; Michael W Otto; Bernard L Harlow
Journal:  Arch Gen Psychiatry       Date:  2006-04
View more
  51 in total

Review 1.  Perimenopause and cognition.

Authors:  Gail A Greendale; Carol A Derby; Pauline M Maki
Journal:  Obstet Gynecol Clin North Am       Date:  2011-09       Impact factor: 2.844

Review 2.  Cognitive Changes with Reproductive Aging, Perimenopause, and Menopause.

Authors:  Kelly N Morgan; Carol A Derby; Carey E Gleason
Journal:  Obstet Gynecol Clin North Am       Date:  2018-10-25       Impact factor: 2.844

Review 3.  Perimenopause as a neurological transition state.

Authors:  Roberta D Brinton; Jia Yao; Fei Yin; Wendy J Mack; Enrique Cadenas
Journal:  Nat Rev Endocrinol       Date:  2015-05-26       Impact factor: 43.330

Review 4.  Strategies for Preventing Cognitive Decline in Healthy Older Adults.

Authors:  Julie A Dumas
Journal:  Can J Psychiatry       Date:  2017-07-13       Impact factor: 4.356

Review 5.  Aging and Neurocognitive Functioning in HIV-Infected Women: a Review of the Literature Involving the Women's Interagency HIV Study.

Authors:  David E Vance; Leah H Rubin; Victor Valcour; Drenna Waldrop-Valverde; Pauline M Maki
Journal:  Curr HIV/AIDS Rep       Date:  2016-12       Impact factor: 5.071

6.  The 2012 hormone therapy position statement of: The North American Menopause Society.

Authors: 
Journal:  Menopause       Date:  2012-03       Impact factor: 2.953

7.  An update on the cognitive impact of clinically-used hormone therapies in the female rat: models, mazes, and mechanisms.

Authors:  J I Acosta; R Hiroi; B W Camp; J S Talboom; H A Bimonte-Nelson
Journal:  Brain Res       Date:  2013-01-16       Impact factor: 3.252

8.  Cognitive complaints after breast cancer treatments: examining the relationship with neuropsychological test performance.

Authors:  Patricia A Ganz; Lorna Kwan; Steven A Castellon; Amy Oppenheim; Julienne E Bower; Daniel H S Silverman; Steve W Cole; Michael R Irwin; Sonia Ancoli-Israel; Thomas R Belin
Journal:  J Natl Cancer Inst       Date:  2013-04-19       Impact factor: 13.506

9.  Hormonal environment affects cognition independent of age during the menopause transition.

Authors:  Alison Berent-Spillson; Carol C Persad; Tiffany Love; MaryFran Sowers; John F Randolph; Jon-Kar Zubieta; Yolanda R Smith
Journal:  J Clin Endocrinol Metab       Date:  2012-06-22       Impact factor: 5.958

10.  Cognition in perimenopause: the effect of transition stage.

Authors:  Miriam T Weber; Leah H Rubin; Pauline M Maki
Journal:  Menopause       Date:  2013-05       Impact factor: 2.953

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.